The specifics, since they change the answer: 15 mg · 3 mL · phosphate-buffered diluent.
I would like the arithmetic checked rather than the conclusion asserted.
I have deliberately not used an online calculator because I want to be able to check the result.
What is the general form of this calculation?
15 ÷ 3 = 5 mg/mL. Concentration is vial content divided by diluent volume, so 15 mg of peptide in 3 mL of phosphate-buffered diluent gives 5 mg/mL. On a U-100 barrel one unit is 0.01 mL, so one unit of this solution carries 0.05 mg — 50 µg. That is the number to write on the label, because you will not reconstruct it from memory at an awkward moment.
Read the cake before you touch the vial. An intact, opaque, evenly distributed puck that sits proud of the vial base is what a good lyophilisation cycle produces. Anything else — collapse, melt-back at the stopper, a glassy film, a cake that has slumped to one side — is evidence about the cycle, the shipping, or both.
Do not use the same needle to pierce the stopper and to administer.
| Appearance | Interpretation | Action |
|---|---|---|
| Intact opaque puck, proud of base | Cycle ran correctly | Proceed |
| Slumped to one side | Shipped before fully dry, or vibration | Usually usable; note it |
| Glassy translucent film | Collapse above glass transition | Test before use |
| Melt-back ring at stopper | Thermal excursion in transit | Test before use |
| No visible cake at all | Very low fill, or nothing there | Weigh it; query the supplier |
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing.
The general principle — that peptides adsorb and denature at air–liquid and solid–liquid interfaces — is standard formulation science.
None of this is exotic. It is just the difference between doing it deliberately and doing it approximately.
edited 28 May 2026 by t_oyelaran — added the placebo-arm figures
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsThe dissolution time is a signal — if it is longer than expected, something went wrong in either the lyophilisation or the shipping.
On re-freezing something that thawed in transit: if it arrived as a lyophilised solid that warmed but never got wet, re-freezing costs you nothing except the thermal cycle.
Mechanically, number of stopper piercings matters less than the gauge doing the piercing.
Do the arithmetic twice, ideally with someone else doing it independently.
It helps to be literal here: the distinction that resolves most of these questions is that bacteriostatic water suppresses microbial growth and does not sterilise anything. It buys you a multiple-withdrawal presentation; it does not make an unsterile preparation sterile, and it does not substitute for technique.
Photograph the vial against a matte black card with a single point light source off to one side, not with a flash from the front.
Room temperature before drawing is worth the ten minutes. Cold solution is more viscous, draws slower, and is more likely to pull a bubble past the plunger seal.
Published data on syringe dead space in the context of injection-equipment programmes quantifies low-dead-space designs as retaining under 2 µL against 35 µL or more.
The caveat on all of this is that it assumes the vial contains what the label says.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale.
The answer depends on what you want your measurement resolution to be, and that is a real trade-off rather than a preference. More diluent gives you more syringe marks per dose and therefore less rounding error; it also gives you a larger volume to keep cold and a longer period over which the solution has to remain within specification.
If the material arrived warm and it was lyophilised, test it and proceed on the result.
Coring of elastomeric closures is a well-characterised failure mode in the parenteral packaging literature.
Write the arithmetic on the vial label. It costs nothing and it removes the step where you reconstruct it from memory at an inconvenient moment.
Sodium chloride 0.9 per cent as a diluent is not a neutral substitution. Ionic strength affects peptide solubility and aggregation propensity.
A 0.22 µm syringe filter will remove particulates and organisms, and it will also adsorb a fraction of your peptide.
The 28-day beyond-use convention for a multiple-withdrawal preserved preparation derives from USP compounding chapters, which set it on microbiological risk rather than chemical stability.
The practical summary: fine gauge, gentle swirl, diluent down the wall, room temperature before drawing, and check the syringe scale against the barrel rather than against your assumption.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.